Empowering Care,
One Heart at a Time
Elucid is a medical technology company that develops AI to see invisible features of cardiovascular risk.
The company is dedicated to developing a clinical platform to help physicians deliver CCTA-guided personalized care by providing a more precise view of atherosclerosis, the root cause of cardiovascular disease.
Our Mission Statement
At Elucid, we focus on enabling efficient and transparent clinical insights to help usher in the next generation of CCTA-guided, personalized coronary artery disease care. We develop AI tools to see invisible features of risk and guide personalized, precise treatment based on a detailed analysis of patients’ atherosclerotic disease. Elucid’s platform transforms CT images into a dynamic, interactive map of disease, providing a more precise view of atherosclerosis – the root cause of cardiovascular disease – to help physicians personalize care based on a patient’s individual anatomy.
Elucid Leadership
News, Media & Thought Leadership
- Press Releases
- Press Releases
- In the News
- In the News
- In the News
Where to Find Us: Upcoming Events
Washington Hilton – Washington, DC – March 7-10, 2026
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Stay in Touch
Subscribe to our newsletter for the latest clinical, product and regulatory updates.